Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Susan Desmond-Hellmann Elected as HHMI Trustee

Published: Thursday, November 08, 2012
Last Updated: Thursday, November 08, 2012
Bookmark and Share
Desmond-Hellmann becomes one of 11 Trustees of the Institute.

Susan D. Desmond-Hellmann, M.D., M.P.H., chancellor of the University of California, San Francisco (UCSF), has been elected a Trustee of the Howard Hughes Medical Institute.

She becomes one of 11 Trustees of the Institute, a medical research organization dedicated to the discovery and dissemination of new knowledge in the life sciences.

Desmond-Hellmann, 55, became chancellor of UCSF in 2009. She is also the Arthur and Toni Rembe Rock Distinguished Professor at UCSF.

An oncologist and renowned biotechnology leader, she spent 14 years at Genentech, serving as president of product development from 2004 to 2009.

In that role, she was responsible for Genentech’s pre-clinical and clinical development, process research and development, business development, and product portfolio management.

During her tenure, Desmond-Hellmann led efforts to bring a number of breakthrough cancer medicines, including Herceptin for breast cancer, to the marketplace.

Prior to joining Genentech, she was associate director of clinical cancer research at Bristol-Myers Squibb Pharmaceutical Research Institute, where she was the project team leader for the cancer-fighting drug Taxol.

Desmond-Hellmann is board-certified in internal medicine and medical oncology. She holds a B.S. in pre-medicine and a medical degree from the University of Nevada, Reno, and a master’s degree in public health from the University of California, Berkeley.

She completed her clinical training at UCSF, where she has served as associate adjunct professor of epidemiology and biostatistics. She also spent two years studying HIV and cancer at the Uganda Cancer Institute.

Desmond-Hellmann is a member of the American Academy of Arts and Sciences and the Institute of Medicine. She was named Woman of the Year in 2006 by the Healthcare Businesswomen’s Association and inducted into the Biotech Hall of Fame in 2007.

In 2009, Forbes magazine named Desmond-Hellman one of the world’s seven most powerful innovators. She was one of Fortune magazine’s “50 most powerful women in business” in 2001 and from 2003 to 2008.

In December 2010, Desmond-Hellmann was appointed to the Board of Procter & Gamble. In January 2009, she joined the Federal Reserve Bank of San Francisco’s Economic Advisory Council for a three-year term.

In July 2008, she was appointed to the California Academy of Sciences board of trustees and, in 2012, to the Albert and Mary Lasker Foundation's board of directors.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

A Crisper View of DNA-Snipping Enzyme
HHMI scientists have created a portrait of a DNA-snipping protein called Cas9, a powerful research tool used in many labs for genome editing.
Saturday, February 08, 2014
Crash-Test Reveals DNA Traffic Control
Researchers have discovered that when DNA-copying enzymes run head-on into oncoming traffic, they kick the obstacles out of their way.
Friday, January 29, 2010
New Strategy Reveals Targets for MicroRNA Gene Regulation
Researchers use HITS-CLIP technique to map the binding points of scores of different microRNAs throughout a genome in living mouse or human tissue.
Friday, June 19, 2009
New Studies Reveal Broad, Hidden Network that Lets Tumors Thrive
Howard researchers identify potential new drug targets for cancers long deemed “untouchable” due to the type of genetic mutation they contain.
Monday, June 01, 2009
Scientists Find RNA Surprises in Listeria Bacteria
HHMI scientists studies the molecular mechanisms that transform Listeria monocytogenes from a harmless soil-dweller to a dangerous human pathogen.
Wednesday, May 20, 2009
Scientists Discover How UV Radiation Causes Cells to Die to Avoid Cancer Damage
Scientists identify the built-in safety mechanism that forces cells damaged by UV radiation to commit suicide to avoid harmful mutations.
Friday, May 15, 2009
Monitoring Cell-Wide Protein Production with Ribosome Profiling
Researchers developed a tool that can capture and quantify protein synthesis; providing a new way to take a “protein census” of living cells.
Monday, February 16, 2009
RNA Interference Knocks Down Prion Genes in Livestock
The strategy might be used to protect animals against influenza or foot-and-mouth disease.
Wednesday, March 29, 2006
Scientific News
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!